Fujifilm Secures DIN-PACS IV Contract From US Department of Defense
Company’s Solutions to Play Key Role in MHS Genesis Project
STAMFORD, CT – August 23, 2017 — FUJIFILM Medical Systems USA., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, today announced that it has earned a new 10-year contract with a maximum value of $768 million as part of the Digital Imaging Network-PACS (DIN-PACS) IV project from the US Department of Defense (DoD) and the US Department of Veterans Affairs. Specifically, US government healthcare providers can now purchase and install various technologies from Fujifilm’s Synapse enterprise imaging portfolio including Synapse 5 PACS, Synapse Mobility Enterprise Web Viewer, Synapse 3D, Synapse CV (Cardiovascular) and Synapse VNA (Vendor Neutral Archive).
Fujifilm’s technology will play a significant role in the MHS Genesis transition—a project that will replace the current electronic health system (EHR) used by the DoD and Veterans Affairs. Specifically, MHS GENESIS integrates inpatient and outpatient best-of-suite solutions that connect medical and dental information across the continuum of care, from point of injury to the military treatment facility. MHS GENESIS will support the availability of electronic health records for more than 9.4 million DoD beneficiaries and approximately 205,000 Military Health System personnel globally. It enables the application of standardized workflows, integrated healthcare delivery, and data standards for the improved and secure electronic exchange of medical and patient data.
“Fujifilm is honored to be awarded yet another impressive contract from the DoD, a valued customer that places great trust in our product and services, and our experienced team of professionals who have the knowledge to ensure smooth implementations,” said Bill Lacy, Vice President of Medical Informatics at FUJIFILM Medical Systems USA, Inc. “This DIN-PACS IV achievement speaks to the fact that Fujifilm operates its business at the highest-quality standards enabling FUJIFILM to provide world class healthcare solutions to our US Service members and Veterans. We are proud to have the proven ability to deploy our systems on the most secured networks in the world.”
With a five-year base period and a five-year renewal option, the Fujifilm systems covered under the DIN-PACS IV contract are now available to the DoD, the US Department of Veterans Affairs, and other federal agencies are eligible to purchase from DIN-PACS IV, including Indian Health Services. To date, 29 facilities have already installed Fujifilm Synapse systems globally.
Enterprise Imaging is rapidly evolving as a necessary organizational priority for health systems across the globe and Fujifilm’s Synapse portfolio is the most comprehensive solution available today. Fujifilm’s Synapse solutions under the DIN-PACS IV contract provide core technology to allow US government healthcare organizations to deploy an Enterprise Imaging strategy that addresses modern IT architecture needs, security, cost savings, operational efficiencies, physician needs, improved outcomes and diagnostic imaging excellence.
FUJIFILM Medical Systems USA, Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems USA, Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems USA, Inc. is headquartered in Stamford, CT. For more information please visit fujifilmhealthcare.com and fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2016, the company had global revenues of $22.1 billion, at an exchange rate of 112.54 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: fujifilmholdings.com.
Manager, Marketing Communications
FUJIFILM Holdings America Corporation
200 Summit Lake Drive
Valhalla, NY 10595